Skip to content

INTERMOLECULAR INC

Delisted

CIK 1311241fmd_1J8FKERE2VV08ZE7WV1C0GTYHBManufacturing · Semiconductors & Related DevicesTemplate: Standard

Coverage: Jan 01, 2010 to Jun 30, 2019, 35 periods

Latest annual · FY2018

Millions
Total revenues
34
Gross profit
24
Operating income
(4)
Net income
(3)
Free cash flow
5

Latest quarter · Q2 FY2019

Millions
Total revenues
5
Gross profit
3
Operating income
(6)
Net income
(5)
Free cash flow
(4)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2015 to FY2018
-9.4%
Revenue, 5 yearsFY2013 to FY2018
-13.0%
Net income, 5 yearsFY2013 to FY2018
n/m

INTERMOLECULAR INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2018FY2017ChangeSource
Revenue$33.7 million$37.2 million-9.5%10-K 2019-03-08 · proof
Gross profit$23.7 million$25.1 million-5.8%10-K 2019-03-08 · proof
Operating income-$4.3 million-$11 million10-K 2019-03-08 · proof
Net income-$3.4 million-$10.4 million10-K 2019-03-08 · proof
Cash from operating activities$5.9 million-$873,00010-K 2019-03-08 · proof
Free cash flow$4.7 million-$1.7 million10-K 2019-03-08 · proof
Total assets$43.4 million$44.3 million-2.1%10-K 2019-03-08 · proof
Total liabilities$9 million$8.2 million+9.4%10-K 2019-03-08 · proof
Cash and cash equivalents$8.4 million$6.1 million+37.1%10-K 2019-03-08 · proof
What was INTERMOLECULAR INC's revenue in fiscal 2018?
INTERMOLECULAR INC reported revenue of $33.7 million for fiscal 2018 (the year ended Dec 31, 2018), against $37.2 million the year before (-9.5%). Source: the 10-K filed with the SEC on Mar 8, 2019. SEC
What was INTERMOLECULAR INC's gross profit in fiscal 2018?
INTERMOLECULAR INC reported gross profit of $23.7 million for fiscal 2018 (the year ended Dec 31, 2018), against $25.1 million the year before (-5.8%). Source: the 10-K filed with the SEC on Mar 8, 2019. SEC
What was INTERMOLECULAR INC's operating income in fiscal 2018?
INTERMOLECULAR INC reported operating income of -$4.3 million for fiscal 2018 (the year ended Dec 31, 2018), against -$11 million the year before. Source: the 10-K filed with the SEC on Mar 8, 2019. SEC
What was INTERMOLECULAR INC's net income in fiscal 2018?
INTERMOLECULAR INC reported net income of -$3.4 million for fiscal 2018 (the year ended Dec 31, 2018), against -$10.4 million the year before. Source: the 10-K filed with the SEC on Mar 8, 2019. SEC
What was INTERMOLECULAR INC's cash from operating activities in fiscal 2018?
INTERMOLECULAR INC reported cash from operating activities of $5.9 million for fiscal 2018 (the year ended Dec 31, 2018), against -$873,000 the year before. Source: the 10-K filed with the SEC on Mar 8, 2019. SEC
What was INTERMOLECULAR INC's free cash flow in fiscal 2018?
INTERMOLECULAR INC reported free cash flow of $4.7 million for fiscal 2018 (the year ended Dec 31, 2018), against -$1.7 million the year before. Source: the 10-K filed with the SEC on Mar 8, 2019. SEC
What are INTERMOLECULAR INC's total assets?
As of Dec 31, 2018, INTERMOLECULAR INC reported total assets of $43.4 million, against $44.3 million a year earlier (-2.1%). Source: the 10-K filed with the SEC on Mar 8, 2019. SEC
What are INTERMOLECULAR INC's total liabilities?
As of Dec 31, 2018, INTERMOLECULAR INC reported total liabilities of $9 million, against $8.2 million a year earlier (+9.4%). Source: the 10-K filed with the SEC on Mar 8, 2019. SEC
What are INTERMOLECULAR INC's cash and cash equivalents?
As of Dec 31, 2018, INTERMOLECULAR INC reported cash and cash equivalents of $8.4 million, against $6.1 million a year earlier (+37.1%). Source: the 10-K filed with the SEC on Mar 8, 2019. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1311241&period_type=annual&limit=5"

Information only, not investment advice.